NimbleRx’s Post

💊🌐 Dive into the future of pharmacy! Discover the fascinating world of personalized medicine and digital therapeutics and how they're revolutionizing healthcare.

Neil Johnson, Partner, Healthcare Development & Innovation Group (HDIG), explores how partnerships and investments can turn ideas into transformative healthcare ventures at the #USSEHIS 🤝 Infor, Aprio, Four Points Health, ScaleHealthTech, Syntax Health, AdhereTech, Dexcom, Nixon Law Group, OXOS Medical, Virtual Therapeutics #HealthcareInnovation #VentureStudios #USSEHIS

Hello World! At Crovelis, we believe that the future of clinical research is here. We’re dedicated to shaping the future of biopharma innovation by setting new standards in clinical research, driven by technology and an unyielding dedication to excellence. The evolution of clinical research and development has brought us to a pivotal moment. With our innovative approach, we aim to set new industry standards, drive groundbreaking discoveries, and accelerate the journey from laboratory insights to life-changing treatments. Our mission is clear: to harness the power of unparalleled human ingenuity and emerging artificial intelligence to deliver faster, safer, and more effective therapeutic solutions. We’re committed to pushing the boundaries of what’s possible and ensuring that patient care and treatment experiences are at the forefront of our endeavors. Join us as we embark on this exciting journey. Follow us for updates, insights, and stories about how we’re revolutionizing clinical research to make a lasting impact on global healthcare. Here’s to a future where science, technology, and human ingenuity come together to create a healthier world. #CrovelisInnovates #HealthcareRevolution #AIinHealthcare #ClinicalResearch #Innovation #PatientCare #MedicalBreakthroughs #TeamCrovelis #HealthcareInnovation #FutureOfMedicine

🚨 scoop alert! After conducting management presentations, Webster Equity's auction process for clinical site manager CenExel has gone pencils down, two sources familiar with the matter told me. This is the second attempt to sell the business. Why it matters: While pharma services is a hot area for private equity, valuation uncertainty is putting a wrench in the health care dealmaking gears. read more below 👇

infuse Life Science, Inc., a pioneering research-driven startup focused on revolutionizing the life sciences for the Ob-GYN healthcare industry, today announced that it has been selected as a finalist of the Tokyo SME grant. This grant will support the development of the company's second product, which follows its previously Tokyo SME grant-selected diagnostic method. The selection is an important step to the company's commitment to innovation and its strong track record in research and development. This latest product, combined with our existing diagnostic solution, will enable us to offer a comprehensive suite of products to address unmet needs in the life sciences field. “This notification of grant approval is a testament to the broader understanding of our vision beyond a single product, but as a comprehensive solution,” said Dai Saito, CEO of infuse Life Science, Inc. “We are committed to working diligently to bring these products to clinical implementation as soon as possible.” https://lnkd.in/egMDHsTQ

More than 100 healthcare leaders from life sciences, academia, payers, providers, and venture capital convened at the Center for Connected Medicine for our Top of Mind Summit: Life Sciences event to discuss ⤵️ 🔍The growing importance of data-driven decision-making to boost innovation and patient care. 🤝Breaking down silos between healthcare stakeholders like pharma, payers, and providers. 💡The crucial role of big data and AI tools in advancing clinical trials and improving patient recruitment. More details from #TopofMind ➡️https://lnkd.in/e5_zu6hV

Connected devices and digital health are key to improving patient experience and enabling faster, more precise clinical trials. Moderated by Paul Upham, Genentech, panelists discuss approaches to enable connected devices and digital health to improve patient engagement and adherence as well as improve chances of new therapeutics’ approval and commercialization. Panelists include: • Matthew Keiser, EMD Serono, Inc. • Vince Masciopinto, SHL Medical • Sarah Small, Otsuka Precision Health, Inc. (OPH) Watch the discussion here: https://lnkd.in/dcSThgvd #PODD2025 #connecteddevices #digitalhealth #clinicaltrials #clinicalresearch #patientengagement

If you prefer to read rather than listen or watch, here is a super summary of what Aman Khera EMBA FRAPS FTOPRA shared during our recent conversation. Worldwide Clinical Trials #patientsfirst #thinkglobal Vistatec

I and other members of the Science 37 team will be in Philly for CRAACO: Clinical Research as a Care Option, Mobile in Clinical Trials, and DPHARM: Disruptive Innovations to Modernize Clinical Research the week of 15 September. Let's connect to discuss doing what we do, not because it's easy but because it's the right thing to do to advance access to life changing therapies! #decentralizedtrials #patientcentric #patientaccess

Take a look at the full conversation on #digitalhealth and how it can improve patient experience, better outcomes and even (hopefully) enable faster and more precise clinical trials. #PODD2024